Advertisement
UK markets open in 7 hours 44 minutes

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.79
    -0.02 (-0.02%)
     

  • GOLD FUTURES

    2,330.10
    -8.30 (-0.35%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,439.58
    -1,739.75 (-3.27%)
     

  • CMC Crypto 200

    1,385.11
    -38.99 (-2.74%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

CordenPharma enters into a technology alliance agreement with Nanos of South Korea

CordenPharma
·1-min read

SEOUL, South Korea, March 29, 2021 (GLOBE NEWSWIRE) -- CordenPharma of Germany entered into a technology alliance agreement with Nanos (151910 KOSDAQ) of South Korea relating to the production of Peptides.

Nanos is a top supplier of camera modules for Samsung Electronics’ mobile phone business.

Due to a relocation of Samsung Electronics’ mobile business to Vietnam, Nanos’ manufacturing factory in Hwasung, Korea, remains out of production.

Through in-licensing or a large-scale direct investment, Nanos plans to transform and utilize the existing production facility to launch high value products, such as Peptides, a potential agent for cancer immunotherapy drugs.

ADVERTISEMENT

Nanos’ partnership with CordenPharma, one of the leading global development and manufacturing organizations (CDMO), represents Nanos’ strategic intention to establish long-term production and sale of therapeutic drugs involving Peptides, which are currently in Phase 2 clinical trials.

Press Contact: Kenny Bang
E-mail : supergto314151@gmail.com